Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Mehalick currently holds 2,768,611 shares of Coeptis Therapeutics Inc. (COEP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Mehalick has been a net buyer of COEP stock. They have purchased $16.7K and sold $0 worth of shares.
David Mehalick's most recent insider trade was on Jan 8, 2024, when they purchased 6,000 shares at $0.67 per share.
David Mehalick serves as Executive at Coeptis Therapeutics Inc. (COEP). They have executed 5 insider transactions totaling $16.7K over their tenure at the company.
David Mehalick holds the position of Executive at Coeptis Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
David Mehalick has shown a buying trading pattern, with $16.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David Mehalick was on Jan 8, 2024, when they purchased $9.2K worth of COEP shares. This transaction involved 14,004 shares at $0.66 per share.
David Mehalick currently owns 2,768,611 shares of Coeptis Therapeutics Inc. (COEP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Mehalick's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Mehalick has 5 Form 4 filings on record as an insider at Coeptis Therapeutics Inc..
Set alerts for David Mehalick and 40,000+ other insiders.